We are live on ! Find out more
ADILW

Adial Pharmaceuticals Warrant
ADILW

Delisted

ADILW was delisted on the 27th of July, 2023.

Back to rankings

3 hedge funds and large institutions have $5K invested in Adial Pharmaceuticals Warrant in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

0% more capital invested

Capital invested by funds: $5K → $5K ($0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$117

Top Sellers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
-$162
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$3K +$117 +490 +3%
UBS Group
2
UBS Group
Switzerland
$2K – – –
WAM
3
Wolverine Asset Management
Illinois
– -$162 -677 -52%

ADILW Hedge Fund Activity: Q3 2019 in Review

3 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals Warrant (ADILW) for Q3 2019, worth a combined $5K — unchanged from a quarter earlier.

Fund positioning in ADILW was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $117. The largest seller was Wolverine Asset Management, cutting an estimated $162.

  • 3 institutional investors held Adial Pharmaceuticals Warrant (ADILW) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $5K of Adial Pharmaceuticals Warrant stock for Q3 2019, unchanged quarter-over-quarter.
  • 0 funds opened new Adial Pharmaceuticals Warrant positions in Q3 2019 and 0 closed out.
  • The largest Adial Pharmaceuticals Warrant buyer in Q3 2019 was Susquehanna International Group, an estimated $117 added.
  • The largest Adial Pharmaceuticals Warrant seller in Q3 2019 was Wolverine Asset Management, an estimated $162 sold.

Based on aggregated 13F filings for Q3 2019.